-
Study aim
-
Investigating the effect of low-level laser therapy on pain reduction of anterior maxillary infiltration injection
-
Design
-
Clinical trials with cross over, triple blind, randomized groups
-
Settings and conduct
-
For each person, two infiltration Injections will be performed in two weeks intervals on both sides of the anterior maxilla (On one side, the control and on the other, the intervention will be carried out). Before starting, the patients are provided with two set envelopes which identifies the control or the intervention in the first turn and in the next turn, the reverse will be carried out. After the selection of the envelope by the patient, the first administer will adjust the device according to the envelope chosen by the patient. Then, the second administrator will apply the low-level laser for 90 seconds without being informed of the device’s setting and immediately the 4% lidocaine (epinephrine 1:100000) will be injected. Afterwards, the patient will determine the pain intensity according to the visual analogue scale. This study has been designed in three ways and the participant, the injector and the data analysts would be unaware of the radiation or inactivation of the laser before injection.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: General health, Absence of pathologic lesion at the injection site, Age range from 20 to 25 years, In need of restoration or root treatment.
Exclusion criteria: Allergy to Lidocaine injectable drug, Use of any sedative and anti-depression drugs in two weeks period.
-
Intervention groups
-
Intervention group: laser radiation with power of 100 mw, then infiltration injection in maxilla with lidocaine 4% solution with epinephrine 1:100000. control group: laser radiation with power of 0 mw, then infiltration injection in maxilla with lidocaine 4% solution with epinephrine 1:100000
-
Main outcome variables
-
Intensity of injection pain